Patents by Inventor Guoqiang Sun

Guoqiang Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11976084
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: May 7, 2024
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Guoqiang Wang, Ruichao Shen, Jun Ma, Yong He, Xuechao Xing, Hui Cao, Xuri Gao, Xiaowen Peng, Joseph D. Panarese, Yat Sun Or
  • Publication number: 20240140984
    Abstract: The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
    Type: Application
    Filed: May 4, 2023
    Publication date: May 2, 2024
    Inventors: Guoqiang WANG, Yat Sun OR, Ruichao SHEN, Jiang LONG, Peng DAI, Xuechao XING, Jing HE
  • Publication number: 20240132476
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof: which inhibit the Apoptosis signal-regulating kinase 1 (ASK-1), which is associated with autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, cardiovascular disease. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from ASK-1 related disease. The invention also relates to methods of treating an ASK-1 related disease in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention specifically relates to methods of treating ASK-1 associated with hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: October 25, 2023
    Publication date: April 25, 2024
    Inventors: Guoqiang Wang, Ruichao Shen, Brett Granger, Jing He, Xuechao Xing, Yong He, Jiang Long, Jun Ma, Bin Wang, Yat Sun Or
  • Patent number: 11958879
    Abstract: The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof, The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR-mediated or TGR5-mediated diseases or conditions.
    Type: Grant
    Filed: May 19, 2021
    Date of Patent: April 16, 2024
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Guoqiang Wang, Yat Sun Or, Ruichao Shen, Xuechao Xing, Jiang Long, Peng Dai, Brett Granger, Jing He
  • Patent number: 11956147
    Abstract: A data transmission method, apparatus, and device, and a computer storage medium are provided. The method includes: obtaining an application packet of a target application; transmitting the application packet to a first routing device by using a network data channel, and transmitting, by using the first routing device, the application packet to a proxy server; meanwhile, transmitting the same application packet to a second routing device by using a short-range wireless data channel different from the network data channel, and transmitting, by using the second routing device, the application packet to the proxy server. The proxy server performs, a deduplication mechanism on the application packet and transmit the application packet to an application server corresponding to the target application.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: April 9, 2024
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Jingjing Hao, Dan Zhang, Binhui Ning, Xiaobo Hu, Feihu Sun, Liuteng Li, Jianbo Xu, Zhenlin Huang, Shuai Ma, Guoqiang Che
  • Patent number: 11945824
    Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV) or HMPV. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV or HMPV infection. The invention also relates to methods of treating an RSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: April 2, 2024
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Yong He, Kevin McGrath, Ruichao Shen, Adam Szymaniak, Xuechao Xing, In Jong Kim, Guoqiang Wang
  • Patent number: 11919910
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 9, 2022
    Date of Patent: March 5, 2024
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Guoqiang Wang, Ruichao Shen, Xuechao Xing, Yong He, Matthew C. Rhodes, Yat Sun Or
  • Patent number: 11912714
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 9, 2022
    Date of Patent: February 27, 2024
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Hui Cao, Wei Li, Xuri Gao, Jiajun Zhang, Xiaowen Peng, Jorden Kass, Ruichao Shen, Guoqiang Wang, Yat Sun Or
  • Publication number: 20240011483
    Abstract: The present disclosure relates to a dual gerotor apparatus. The dual gerotor apparatus comprises a housing configured to provide a first and second hydraulic fluid circuit sharing a single inlet and a single outlet. The dual gerotor apparatus further comprises a gerotor assembly coupling with a rotatable shaft, the gerotor assembly is configured to transfer a hydraulic fluid flowing through the first or second hydraulic fluid circuit from the single inlet to the single outlet. The gerotor comprises a first gerotor pump and a second gerotor pump, the first gerotor pump will be in operation when the rotatable shaft rotates in a first direction, and the second gerotor pump will be in operation when the rotatable shaft rotates in a second direction.
    Type: Application
    Filed: August 17, 2021
    Publication date: January 11, 2024
    Applicant: VALEO POWERTRAIN (NANJING) CO., LTD.
    Inventors: Yejin JIN, Kai CHEN, Guoqiang SUN
  • Publication number: 20230336049
    Abstract: A rotary electric machine includes a rotor configured for coupling with a rotary shaft and a stator configured for surrounding the rotor, the stator includes a stator body and stator end windings which extend from axial ends of the stator body. The rotary electric machine further includes a housing configured for receiving the stator and rotor, the housing includes a fluid distributing chamber provided along an inner surface of the housing for being communicated with a plurality of fluid channels so as to distribute the fluid to flow through outer surfaces of the stator body and stator end windings when the stator is inserted into the housing. The present disclosure further relates to a powertrain assembly and an electrified vehicle including the rotary electric machine.
    Type: Application
    Filed: September 1, 2021
    Publication date: October 19, 2023
    Applicant: VALEO POWERTRAIN (NANJING) CO., LTD.
    Inventors: Yejin JIN, Kai CHEN, Guoqiang SUN
  • Patent number: 11714402
    Abstract: A universal automatic test system for a digital plugboard based on imagine processing, includes a digital plugboard test platform, an image acquisition and processing module, a test instrument module and a control and processing module. The universal automatic test system can determine a type of the digital plugboard and a point to be test based on the image of the digital plugboard, and call a corresponding automatic test program to complete the test of each point. A type of the output signal can be obtained through the universal automatic test system. By moving the detection probe, the any position of the digital plugboard can be test, and a fault portion of the digital plugboard can be obtained according to the test result.
    Type: Grant
    Filed: August 17, 2022
    Date of Patent: August 1, 2023
    Assignee: 38TH RESEARCH INSTITUTE, CHINA ELECTRONICS TECHNOLOGY GROUP CORPORATION
    Inventors: Guoqiang Sun, Fangning Tian, Wenqing Tong, Yifeng Bai, Fengtao Shu, Jianjun Su
  • Publication number: 20230095676
    Abstract: A method for multi-task-based predicting massive-user loads based on a multi-channel convolutional neural network, and belongs to the technical field of electric power systems. The method includes clustering all residential users into a plurality of clusters with different daily average electricity consumption modes by adopting an agglomerative hierarchical clustering method. Corresponding input data sets are constructed for various clusters by adopting a multi-channel-based multi-source input fusion method. Then, a multi-task-based load prediction model based on a convolutional neural network is established for each of the clusters. Load prediction values for different users in the corresponding cluster are output in parallel by each model to eventually obtain load prediction results of all of the residential users.
    Type: Application
    Filed: September 27, 2022
    Publication date: March 30, 2023
    Inventors: Haixiang ZANG, Ruiqi XU, Fengchun ZHANG, Xin JIANG, Zhinong WEI, Guoqiang SUN
  • Publication number: 20220390932
    Abstract: A universal automatic test system for a digital plugboard based on imagine processing, including a digital plugboard test platform, an image acquisition and processing module, a test instrument module and a control and processing module.
    Type: Application
    Filed: August 17, 2022
    Publication date: December 8, 2022
    Inventors: Guoqiang SUN, Fangning TIAN, Wenqing TONG, Yifeng BAI, Fengtao SHU, Jianjun SU
  • Publication number: 20220276329
    Abstract: Disclosed are an intelligent instrument verification system and method. The intelligent instrument verification system includes an automatic verification system, a reference instrument group and a communication control interface. The automatic verification system is connected to an instrument to be verified through the communication control interface. The automatic verification system is connected to the reference instrument group through the communication control interface. The reference instrument group is connected to the instrument to be verified through the communication control interface.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 1, 2022
    Inventors: Guoqiang SUN, Fangning TIAN, Jianjun SU, Wenqing TONG, Yifeng BAI
  • Publication number: 20210300998
    Abstract: Disclosed are methods of producing human iPSC-derived brain organoids and uses thereof to detect and develop treatment for HCMV-induced brain deformation in developing fetus.
    Type: Application
    Filed: March 22, 2021
    Publication date: September 30, 2021
    Applicant: CITY OF HOPE
    Inventors: Yanhong SHI, Guoqiang SUN, Xianwei CHEN
  • Patent number: 9751810
    Abstract: The invention claims a flame-retardant and corrosion-resistant fiber bamboo substrate and a preparation method thereof. The preparation method comprises the following steps of: 1) cutting raw bamboo into bamboo filaments; 2) flame-retardant treatment: soaking the bamboo filaments prepared in Step 1) in aqueous solution of a flame retardant; 3) drying: drying the flame-retardant treated bamboo filaments at 55° C. to 65° C. until the absolute water content is not more than 12%; 4) carbonized pyrolysis: feeding the dried bamboo filaments into a carbonized pyrolysis kiln, to be high-temperature treated according to a pyrolysis gradient; and, 5) sequentially gumming, post-gumming drying, pressing, curing, maintaining and splitting to obtain a bamboo substrate. The bamboo substrate has high stability, no cracks on the product surface, enhanced corrosion resistance and excellent flame retardance, and may be used in various climate conditions and environments.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: September 5, 2017
    Assignee: WUXI BODA BAMBOO AND WOOD INDUSTRIAL CO., LTD.
    Inventor: Guoqiang Sun
  • Publication number: 20150128827
    Abstract: A preparation method for a flame-retardant and corrosion-resistant fiber bamboo substrate comprises the following steps of: 1) cutting raw bamboo into bamboo filaments; 2) flame-retardant treatment: soaking the bamboo filaments prepared in Step 1) in aqueous solution of a flame retardant; 3) drying: drying the flame-retardant treated bamboo filaments at 55° C. to 65° C.; 4) carbonized pyrolysis: feeding the dried bamboo filaments into a carbonized pyrolysis kiln; and 5) sequentially gumming, post-gumming drying, pressing, curing, maintaining and splitting to obtain a bamboo substrate.
    Type: Application
    Filed: July 19, 2013
    Publication date: May 14, 2015
    Applicant: Wuxi Boda Bamboo and Wood Industrial Co., Ltd. (CN)
    Inventor: Guoqiang Sun
  • Patent number: 8785180
    Abstract: A biochemical reactor involves an online cell examination microscope thereon. The online cell examination microscope comprises a main body, an objective lens, an observation entrance window, a sampling device, an external light source system. Said observation entrance window lies in front of said main body and the sampling device lies in front of said observation entrance window. An objective lens and said external light source system lie behind the observation entrance window in the main body. A reflector prism is installed between the external light source system and the objective lens. A reflector lies behind the objective lens and in front of the observation entrance window. An annular diaphragm is placed in front of the reflecting prism. A CCD or an area image sensor is arranged on the upper side of the reflectance prism.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: July 22, 2014
    Assignees: Shanghai Guoqiang Bioengineering Equipment Co., Ltd., Shanghai Cohere Electronics Technology Co., Ltd., East China University of Science and Technology
    Inventors: Siliang Zhang, Yuefang Zhang, Jian Liu, Xujun Yuan, Meijin Guo, Liqing He, Gongjian Chen, Ming Zhang, Guoqiang Sun, Wenfeng Ma, Ju Chu, Yingping Zhuang, Yonghong Wang, Mingzhi Huang, Haifeng Hang, Jianye Xia
  • Publication number: 20120015391
    Abstract: A biochemical reactor involves an online cell examination microscope (4) thereon. Said online cell examination microscope (4) comprises a main body (43), an objective lens (24), an observation entrance window (22), a sampling device (40), an external light source system (60). Said observation entrance window (22) lies in front of said main body (43) and the sampling device (40) lies in front of said observation entrance window (22). An objective lens (24) and said external light source system (60) lie behind the observation entrance window (22) in the main body (43). A reflector prism (25) is installed between the external light source system (60) and the objective lens (24). A reflector (23) lies behind the objective lens (24) and in front of the observation entrance window (22). An annular diaphragm (26) is placed in front of the reflecting prism (25). A CCD or an area image sensor (30) is arranged on the upper side of the reflectance prism (25).
    Type: Application
    Filed: August 30, 2010
    Publication date: January 19, 2012
    Applicants: Shanghai Guoqiang Bioengineering Equipment Co., Ltd., East China University of Science and Technology, Shanghai Cohere Electronics Technology Co., Ltd.
    Inventors: Siliang Zhang, Yuefang Zhang, Jian Liu, Xujun Yuan, Meijin Guo, Liqing He, Gongjian Chen, Ming Zhang, Guoqiang Sun, Wenfeng Ma, Ju Chu, Yingping Zhuang, Yonghong Wang, Mingzhi Huang, Haifeng Hang, Jianye Xia